InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (2 ops.)
Browse the full record of transactions filed by Silverman Joshua, Director. Insider active across 3 companies, notably AYRO, Inc.. Cumulatively, 10 reports have been published. Total volume traded: €545k. The latest transaction was disclosed on 1 February 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations10 total
0114,729 shares0
Common Stock
SEC:0001493152-22-003115:0·
0114,729 shares0
Common Stock
SEC:0001493152-22-003115·
€37,7226,734 shares@ €5.6017100.0% of flow
Common Stock
SEC:0001493152-21-029973·
Ideal exit: 21 Aug 2022 (T+270)
€37,7226,734 shares@ €5.601750.0% of flow
Common Stock
SEC:0001493152-21-029973:0·
Ideal exit: 21 Aug 2022 (T+270)
090,000 shares0
Common Stock, par value $0.0001 per share
SEC:0001104659-21-092712·
090,000 shares0
Common Stock, par value $0.0001 per share
SEC:0001104659-21-092712:0·
€68,46910,000 shares@ €6.8469100.0% of flow
Common Stock, par value $0.0001 per share
SEC:0001104659-21-081897·
Ideal exit: 11 Mar 2022 (T+270)
€68,46910,000 shares@ €6.846950.0% of flow
Common Stock, par value $0.0001 per share
SEC:0001104659-21-081897:0·
Ideal exit: 11 Mar 2022 (T+270)
€166,23039,008 shares@ €4.2614100.0% of flow
Common Stock
SEC:0001493152-21-013812·
€166,23039,008 shares@ €4.261450.0% of flow
Common Stock
SEC:0001493152-21-013812:0·
10 of 10 declarations
About Silverman Joshua
Silverman Joshua is a Board Member at AYRO, Inc., Synaptogenix, Inc., and MyMD Pharmaceuticals, Inc. He plays a key role in the governance of these companies, providing strategic advice and overseeing development initiatives.
